Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine ...

We recently published a list of 10 Most Undervalued S&P 500 Stocks to Buy Now. In this article, we are going to take a look ...

Pfizer offers a 6.7% dividend yield, trading at a low valuation with resilient drug portfolio growth. Realty Income Corp. has ...

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

Pfizer’s acquisition of Seagen in December 2023 added antibody ... under the Inflation Reduction Act (IRA), which takes effect in 2025. Higher-priced drugs, including Vyndaqel, Ibrance, Xtandi ...

Higher sales of Pfizer’s key non-COVID products like Vyndaqel, Padcev and Eliquis and newly acquired products from Seagen, coupled with higher Paxlovid sales, drove the top line in the quarter.

In some cases, it may cause side effects such as gastrointestinal problems, numbness, or a fast heart rate. Vyvanse can help improve symptoms associated with ADHD, such as issues with focus and ...